RA PHARMACEUTICALS, INC. Stock-Based Compensation
RA PHARMACEUTICALS, INC. reported Stock-Based Compensation of $14.04 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $3.90M, a 81.93% increase year-over-year.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $3.81M, a 112.42% increase year-over-year.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $3.44M, a 90.12% increase year-over-year.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-03-31 was $2.89M, a 48.51% increase year-over-year.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $14.04M, a 82.52% increase from fiscal 2018.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $7.70M, a 38.08% increase from fiscal 2017.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2017 was $5.57M, a 443.18% increase from fiscal 2016.
- RA PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2016 was $1.03M, a 575.00% increase from fiscal 2015.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.71M derived: sum of 2 quarters · filed 2020-02-27 | $11.15M derived: sum of 3 quarters · filed 2020-02-27 | $14.04M 10-K · filed 2020-02-27 |
| 2019-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $7.26M derived: sum of 2 quarters · filed 2019-11-07 | $10.15M 10-Q · filed 2019-11-07 | $12.29M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $6.33M 10-Q · filed 2019-08-07 | $8.48M derived: sum of 3 quarters · filed 2020-02-27 | $10.27M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $2.89M 10-Q · filed 2019-05-09 | $5.03M derived: sum of 2 quarters · filed 2020-02-27 | $6.83M derived: sum of 3 quarters · filed 2020-02-27 | $8.64M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.94M derived: sum of 2 quarters · filed 2020-02-27 | $5.75M derived: sum of 3 quarters · filed 2020-02-27 | $7.70M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $3.61M derived: sum of 2 quarters · filed 2019-11-07 | $5.55M 10-Q · filed 2019-11-07 | $7.28M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $3.76M 10-Q · filed 2019-08-07 | $5.48M derived: sum of 3 quarters · filed 2019-08-07 | $7.08M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $1.95M 10-Q · filed 2019-05-09 | $3.67M derived: sum of 2 quarters · filed 2019-05-09 | $5.27M derived: sum of 3 quarters · filed 2019-05-09 | $6.50M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.32M derived: sum of 2 quarters · filed 2019-03-07 | $4.55M derived: sum of 3 quarters · filed 2019-03-07 | $5.57M 10-K · filed 2019-03-07 |
| 2017-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.83M derived: sum of 2 quarters · filed 2018-11-07 | $3.85M 10-Q · filed 2018-11-07 | $4.35M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.25M 10-Q · filed 2018-08-08 | $2.75M derived: sum of 3 quarters · filed 2018-08-08 | $3.00M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $1.02M 10-Q · filed 2018-05-09 | $1.52M derived: sum of 2 quarters · filed 2018-05-09 | $1.77M derived: sum of 3 quarters · filed 2018-05-09 | $1.92M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $755.00K derived: sum of 2 quarters · filed 2018-03-14 | $901.00K derived: sum of 3 quarters · filed 2018-03-14 | $1.03M 10-K · filed 2018-03-14 |
| 2016-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $396.00K derived: sum of 2 quarters · filed 2017-11-09 | $521.00K 10-Q · filed 2017-11-09 | $552.00K derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $271.00K 10-Q · filed 2017-08-09 | $302.00K derived: sum of 3 quarters · filed 2018-03-14 | |
| 2016-03-31 | $125.00K 10-Q · filed 2017-05-11 | $156.00K derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2015-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $152.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $121.00K 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | $88.00K 10-K · filed 2017-03-06 |